Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
It is undergoing Phase III trials to evaluate its safety in treating DED caused by dry eye syndrome (NCT05310422 and NCT04819269)
Each vial contains 1mg of lyophilised IGF-1 LR3, manufactured to research-grade standards for use in licensed laboratory and scientific research only
References: [1]
proliferation, migration, and invasion), in PC3 and LNCaP cells regardless of their hormone sensitivity
Phelan McDermid syndrome (PMS) and HelsmoortelVan der Aa syndrome (HVDAS) PMS results from the loss of one functional copy of the SHANK3 gene of chromosome 22q13 [337]
This variability explains why some users tolerate semaglutide with minimal issues while others experience more pronounced symptoms
US$ 21.21
US$ 24.53
US$ 25.47
